Synthesis and tyrosinase inhibitory activities of novel isopropylquinazolinones

被引:0
|
作者
Arshia Hashemi
Milad Noori
Navid Dastyafteh
Seyed Esmaeil Sadat-Ebrahimi
Negin Fazelzadeh Haghighi
Katayoun Mehrpour
Elahe Sattarinezhad
Fatemeh Jalali Zafrei
Cambyz Irajie
Mohammad Ali Daneshmehr
Majid Heydari
Bagher Larijani
Aida Iraji
Mohammad Mahdavi
机构
[1] Tehran University of Medical Sciences,Department of Medicinal Chemistry, Faculty of Pharmacy and Pharmaceutical Sciences Research Center
[2] Tehran University of Medical Sciences,Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute
[3] Shiraz University of Medical Sciences,Molecular Dermatology Research Center and Department of Dermatology
[4] Shiraz University of Medical Sciences,Stem Cells Technology Research Center
[5] Shiraz University of Medical Sciences,Central Research Laboratory
[6] Shiraz University of Medical Sciences,Department of Pharmacology, School of Medicine
[7] Guilan University of Medical Sciences,Cardiovascular Diseases Research Center, Department of Cardiology, Heshmat Hospital, School of Medicine
[8] Shiraz University of Medical Sciences,Department of Medical Biotechnology, School of Advanced Medical Sciences and Technologies
[9] Shiraz University of Medical Sciences,Student Research Committee
来源
BMC Chemistry | / 17卷
关键词
Isopropylquinazolinone; Synthesise; Tyrosinase; Enzyme inhibition; Kinetic evaluation; In silico studies;
D O I
暂无
中图分类号
学科分类号
摘要
To find new anti-browning and whitening agents in this study, new series of isopropylquinazolinone derivatives were designed and synthesized. All derivatives were evaluated as possible tyrosinase inhibitors and compound 9q bearing 4-fluorobenzyl moieties at the R position exhibited the best potencies with an IC50 value of 34.67 ± 3.68 µM. The kinetic evaluations of 9q as the most potent derivatives recorded mix-type inhibition. Compounds 9o and 9q also exhibited potent antioxidant capacity with IC50 values of 38.81 and 40.73 µM, respectively confirming their antioxidant potential. Molecular docking studies of 9q as the most potent derivative were exacuated and it was shown that quinazolinone and acetamide moieties of compound 9q participated in interaction with critical His residues of the binding site. The obtained results demonstrated that the 9q can be considered a suitable pharmacophore to develop potent tyrosinase inhibitors.
引用
收藏
相关论文
共 50 条
  • [31] Inhibitory effects of fermented codonopsis lanceolata on tyrosinase and α-glucosidase activities
    Kim, Seung Seop
    Jeong, Myoung Hoon
    Choi, Woon Yong
    Seo, Yong Chang
    Ahn, Juhee
    Yoon, Won Byoung
    Park, Dong Sik
    Lee, Hyeon Yong
    World Academy of Science, Engineering and Technology, 2010, 41
  • [32] The inhibitory effect of benzenethiol on the cresolase and catecholase activities of mushroom tyrosinase
    Saboury, A. A.
    Zolghadri, S.
    Haghbeen, K.
    Moosavi-Movahedi, A. A.
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2006, 21 (06) : 711 - 717
  • [33] Phenolic Constituents of Carex vulpinoidea Seeds and their Tyrosinase Inhibitory Activities
    Niesen, Daniel B.
    Ma, Hang
    Yuan, Tao
    Bach, Alvin C., II
    Henry, Geneive E.
    Seeram, Navindra P.
    NATURAL PRODUCT COMMUNICATIONS, 2015, 10 (03) : 491 - 493
  • [34] Inhibitory effects of fermented codonopsis lanceolata on tyrosinase and α-glucosidase activities
    Kim, Seung Seop
    Jeong, Myoung Hoon
    Choi, Woon Yong
    Seo, Yong Chang
    Ahn, Juhee
    Yoon, Won Byoung
    Park, Dong Sik
    Lee, Hyeon Yong
    World Academy of Science, Engineering and Technology, 2010, 65
  • [35] Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivatives
    Pau, A
    Asproni, B
    Boatto, G
    Grella, GE
    De Caprariis, P
    Costantino, L
    Pinna, GA
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2004, 21 (04) : 545 - 552
  • [36] Synthesis and PDF inhibitory activities of novel benzothiazolylidenehydroxamic acid derivatives
    Takayama, W
    Shirasaki, Y
    Sakai, Y
    Nakajima, E
    Fujita, S
    Sakamoto-Mizutani, K
    Inoue, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (19) : 3273 - 3276
  • [37] Synthesis and aldose reductase inhibitory activities of novel dibenzocycloheptenone derivatives
    Inoue, J
    Cui, YS
    Rodriguez, L
    Chen, Z
    Kador, PF
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 1999, 34 (05) : 399 - 404
  • [38] Rifampicin as a novel tyrosinase inhibitor: Inhibitory activity and mechanism
    Chai, Wei-Ming
    Lin, Mei-Zhen
    Song, Fang-Jun
    Wang, Ying-Xia
    Xu, Kai-Li
    Huang, Jin-Xin
    Fu, Jian-Ping
    Peng, Yi-Yuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2017, 102 : 425 - 430
  • [39] Inhibitory kinetics of DABT and DABPT as novel tyrosinase inhibitors
    Yang, Mei-Hua
    Chen, Chih-Min
    Hu, Yong-Hua
    Zheng, Cheng-Yi
    Li, Zhi-Cong
    Ni, Lian-Lian
    Sun, Li
    Chen, Qing-Xi
    JOURNAL OF BIOSCIENCE AND BIOENGINEERING, 2013, 115 (05) : 514 - 517
  • [40] Synthesis of novel diazaphosphinanes coumarin derivatives with promoted cytotoxic and anti-tyrosinase activities
    Gardelly, Marwa
    Trimech, Belsem
    Belkacem, Mohamed Amine
    Harbach, Mounira
    Abdelwahed, Soukaina
    Mosbah, Amor
    Bouajila, Jalloul
    Ben Jannet, Hichem
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (10) : 2450 - 2454